chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sensation that something was stuck in her throat (similar to when a tonsil stone is present); Stiffness at injection site; Itching; Sore muscle; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL6269), via an unspecified route of administration in the right arm on 06Feb2021 08:15 at a single dose for COVID-19 immunization. The patient's medical history included sulfa allergy. The patient was not pregnant at the time of vaccination. Concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced sore muscle on 06Feb2021 23:15, stiffness at injection site on 07Feb2021 04:15, itching on 07Feb2021 04:15, and sensation that something was stuck in her throat (similar to when a tonsil stone is present) on 07Feb2021 08:15. No treatment was received for the adverse events. Outcome of the events was recovering.
Sweats; Chills; Fever; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 12May2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, COVID-19 infection. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN), sulfa (sulfonamide) and cefaclor (CECLOR). The concomitant medication included cannabis sativa (CANNABIS) for an unknown indication, from unspecified date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12May2021 at 18:00, the patient experienced chills, sweats, fever, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events chills, sweats, fever, headache and fatigue resolved with sequelae on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
I woke up around 3 am because of body aches. The body aches worsened and i checked and had a fever of 100.6 degrees Fahrenheit. My head started to pound and my pulse was accelerated to probably 80 bpm (normally rest at 60 bpm). I felt a little lightheaded and  a bit nauseas. I took 2 200 mg tablets of EC ibuprofen and did not take Tylenol because i knew my immune response needed to take its course. it is about 3:33 in the afternoon and my body is still aching but my fever has dissipated and I still have a headache that throbs when I walk.
Fussy baby T-99. Red, swollen at site. Advised TYLENOL, cool compresses.
41-year-old female HCW who received Pfizer BioNTech vaccine (Lot # EK5730) on 21 Dec 2020 in her left upper arm. No other vaccines were received that day. She reports a sensation of warmth and tenderness locally right after vaccination. On the evening of vaccination, she noted a small area of redness and swelling at the vaccination site. She denied anything out of the ordinary with regard to vaccine administration, except the vaccine might have been given "a little lower" than usual. She did not experience any respiratory, CV, dermatologic, or gastrointestinal signs/symptoms during observation post-vaccination or during the next several days.  Post-vaccination day (PVD) one, patient noted some tenderness, warmth, redness, and some bruising surrounding the vaccination site. (SEE PVD 1 Photo); local reaction gradually resolved (SEE PVD 7 Photo) and currently, all that remains is a big bruise. On the evening of 26 Dec, patient reported having some "congestion" and took some Nyquil. She reports a good night's sleep, but upon awakening, she noted mild shortness of breath and she "couldn't open" her eyes due to swelling. She also noted her bottom lip and tongue were swollen and she experienced a tight feeling in her throat and chest. She also reports mild swelling of her hands.  She denies hives/urticaria, wheezing, stridor, dysphagia, loss of consciousness, or gastrointestinal-related symptoms. Patient self-treated with oral Benadryl, Pepcid, and Zyrtec, as well as using her Albuterol inhaler. After 2 hours, her symptoms had not improved, so her spouse took her to the Emergency Room. In the ER, she was placed on a cardiac monitor, and shortly after arrival, she received IM Epinephrine (x2), followed by IV Solumedrol. She was observed for 8-10 hours and discharged home with a 5-day course of oral steroids.  She was diagnosed with "anaphylaxis" and instructed to follow-up with her Primary Care Provider. Since discharge, she has continued to note some facial swelling, and on 29 Dec, she was having problems breathing for which she used her inhalers, and symptoms resolved.  On the day of vaccine receipt, patient reports feeling well prior to vaccination. She denies previous vaccine reactions. She denies any exposures that might have been potential triggers to her reaction on 27 Dec  "the only thing different was the vaccine"
As of today Friday 10/29/21 "I" have blisters on the left side of "my" face and am being monitored for eye involvement as it is on my ophthalmic nerve.; numbness on the left side of her face which turned out to be the start of shingles; On Monday 10/25/21 "I" developed a severe headache; pain; numbness on the left side of her face which turned out to be the start of shingles.; Booster dose; This is a spontaneous report from a contactable other hcp (patient). A 32-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: FF8839) via an unspecified route of administration, administered in Arm Right on 20Oct2021 (at the age of 32 year old) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history included covid-19 (Prior to vaccination, was the patient diagnosed with COVID-19?Yes). There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient previously taken amoxicillin/clavulanic acid (AUGMENTIN) and experienced rash as a child. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration on 22Jan2021 (at the age of 32-years-old) as dose 1, single and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration on 12Feb2021 (at the age of 32-years-old) as a dose 2, single for COVID-19 immunisation. On 25Oct2021, on Monday, the patient developed severe headache as well as pain and numbness on the left side of her face which turned out to be the start of shingles. On 29Oct2021, Friday, the patient had blisters on the left side of her face and she was being monitored for eye involvement as it was along the ophthalmic nerve. The adverse events resulted in doctor/other health care professional office/clinic visit. Patient received treatment with valaciclovir (VALACYCLOVIR) 1 gram thrice daily for 10 days and eyedrops. The outcome of the event events was not recovered.  Follow-up attempts are completed. No further information is expected.
Wheezing, asthma, fatigue, leg weakness, and redness swelling, itching at injection site.
Chills, trembling, nausea, dizziness, muscle pain, joint pain, severe headache x36 hrs
28 patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (28 patient received expired vaccine) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (28 patient received expired vaccine). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (28 patient received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD-2021-408551 (Patient Link).
Limited shoulder movement in 24 hours after receiving the shot . Has limitations while driving - while sterring the wheel ,  States the limitation had improved since then - about 50% but still present . He does cold , warm compresses and Advil once a day . States the pain is not in the shoulder but in the muscle few inches below the shoulder . Was seen by Chiropractor and currently been seen by Accupuncture  Seen improvement but not resolved
Bell's palsy; Pain in extremity; This case was received via FDA VAERS (Reference number: 1284039) on 29-Jun-2021 and was forwarded to Moderna on 29-Jun-2021.    This regulatory authority case was reported by an other health care professional and describes the occurrence of BELL'S PALSY (Bell's palsy) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Tetracycline), Blood pressure high (under control) and Cholesterol high (under control). Concomitant products included AMLODIPINE, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), OMEPRAZOLE, SIMVASTATIN, FISH OIL and COENZYME Q10 [UBIDECARENONE] for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced BELL'S PALSY (Bell's palsy) (seriousness criterion medically significant) and PAIN IN EXTREMITY (Pain in extremity). The patient was treated with PREDNISONE for Adverse event, at a dose of 1 dosage form and VALACICLOVIR at a dose of 1 dosage form. At the time of the report, BELL'S PALSY (Bell's palsy) and PAIN IN EXTREMITY (Pain in extremity) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Blood test: inconclusive (Inconclusive) Inconclusive. On 27-Apr-2021, Chest X-ray: inconclusive (Inconclusive) inconclusive. On 27-Apr-2021, Electrocardiogram: inconclusive (Inconclusive) inconclusive. On 27-Apr-2021, Magnetic resonance imaging: inconclusive (Inconclusive) inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included flax. The reporter stated the patient had Bell's palsy on left side of face. Very limited information regarding this events has been provided at this time.; Sender's Comments: Very limited information regarding this events has been provided at this time
8-1-16 got shot that night is started turning red an it kept getting bigger over the next day had no fever.
This patient's mother said that her face was swollen after the shot. No redness, no fever, no other complaint.
This is a 76y.o. female with type 2 diabetes mellitus, obesity, dyslipidemia, and history of lung cancer in 2005 who presents with fatigue and shortness of breath. She also complains of decreased appetite and oral intake. She says she's been feeling progressively worse over the past week. She denies known fever, productive cough, nausea, vomiting, abdominal pain, or diarrhea. She has had a known COVID-19 exposure to her son who tested positive. She is fully vaccinated, but no booster yet.    On arrival to the ED, the patient was tachypneic, tachycardic, and diaphoretic. SpO2 55% on room air and she was placed on non-rebreather mask at 15 L/min. She was afebrile, hypotensive. She did test positive for COVID-19. Chest x-ray shows bilateral patchy airspace opacities concerning for multifocal pneumonia. Random glucose 508, lactic acid 4.0, anion gap 18, creatinine 2.39, sodium 133, magnesium 1.5, WBC 11.4, D-dimer > 10,000. Procalcitonin 0.25. The patient was given insulin, IV fluids, started on empiric heparin drip and admitted for further management.
Pt reported chest tightness similar to reaction after 1st vaccination. Vital signs were stable. Physical exam was within normal limits. Pt was observed in medical tent for 30 mins with symptom resolution
Woke up around 2am after vaccine administration with a very sore arm. Pain went down to forearm and down shoulder and back muscles. Woke up again around 6:30 am with a low grade fever of 99.5 degree F. Took ibuprofen to help bring down the fever and help with the pain. Throughout the day experienced cycles of hot and cold flashes as well as pain around injection site and sharp pains down arm to my fingertips. Symptoms subsided by around 8pm the day after vaccination.
Patient was administered 2 immunizations (Shingrix and Boostrix).  The patient fell twice inthe parking lot, the second time striking his head on the cart corral.  Division 1 filled out a report, the patient went to the hospital and received stiches.  The patient returned to the pharmacy to pick up another (unrelated) script and I spoke to him.  He said the provider said it was possibly related to the immunizations given, but there was no direct evidence to suppport that and they could not say for sure it was related.  The patient stated he was fine inside the store, but when went outside into the heat he became light headed and went down.
on day 8-9 post vaccine pt developed a red itchy rash at injection site.  no pain fevers chills or ssx of infx
Child received 15mcg dose instead of 10mcg dose. Father reports no side effects following vaccination.
Day 1) 20 - 30 minutes after receiving vaccine, I experienced extreme heaviness down the left side of my body and nasal congestion.  4 hours after the shot, the heaviness continued and was very noticeable on the left lung, and caused my breathing to feel constricted.  I began using an albuterol inhaler.  The left lung continued to get worse and I contacted Dr.  I have been on 3 courses of oral steroids and different inhaled steroids in which my lung improves during the treatment; however, the condition returns after treatment.   (prior to receiving the vaccine, the asthma was in good control and I was not experiencing any issues).  A recent CT scan shows the area of inflammation that is giving me difficulties.  I am now on a waiting list to see a pulmonologist. Day 2) The left side of my throat became extremely swollen, making it difficult to swallow.  This lasted for at least a week..
This spontaneous report as received from a healthcare worker refers to an unspecified patients of unknown age and gender. There was no information about concomitant medications, concurrent condition and medical history of patients reported. On an unknown date, improperly stored doses of the GARDASIL, (dose, site, route of administration, lot# and expiry date were not reported) was administered to unspecified patients. No adverse experiences were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Myalgia, Rash, UrticariaPruritis,  INJECTION SITE SWELLING/REDNESS/RASH, FATIGUE, ABDOMINAL CRAMPING, FEELING WARM Narrative:
Body aches - 16 hours after vaccine Fever: 100.4 Moderate to severe headache Body aches Cough
I started with a sore throat and nasal congestion, I suffer from chronic sinus issue so I thought it was that. On the 6th I started feeling bad. I was achy with sore throat, nasal congestion and a crushing headache. I completed a at home COVID-19 test and it was positive. I went to the pharmacy and had a PCR test done and it was also positive. My doctor prescribed PAXLOVID and I started the same day. By Saturday the 9th, I had a sever headache with a metallic taste in my mouth. I was throwing up and the headache was so severe I almost went to the the ER. I continued the PAXLOVID and then my symptoms resolved and by Monday the 11th, I was back to normal. I still have a little fatigue but I feel I have made a complete recovery.
injection site soreness; injection site rash; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection site soreness), INJECTION SITE RASH (injection site rash) and NAUSEA (Nausea) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history was not provided).    On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INJECTION SITE PAIN (injection site soreness) and INJECTION SITE RASH (injection site rash). 12-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, INJECTION SITE PAIN (injection site soreness), INJECTION SITE RASH (injection site rash) and NAUSEA (Nausea) outcome was unknown.
Patient received MENACTRA on 8/17/10 (L) arm IM. Mom called next day reporting his arm swollen at site 4 inches across and 5 inches high. Advised icing area. Ibuprofen OTC. To come in if no improvement. Had redness & sore. No fever no swelling.
Ringing in ears. Began evening of first dose and remained. After second dose on 2/18/2021 the ringing is louder
had the first shot in Mar2021, after that he had pain in the arm that was about a 4 out of 10 on a pain scale/With the second shot, it was the same way; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 80 year-old male patient received bnt162b2 (BNT162B2), administered in arm, administration date 2021 (Batch/Lot number: unknown) as dose 2, single and administered in arm, administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "had the first shot in Mar2021, after that he had pain in the arm that was about a 4 out of 10 on a pain scale/With the second shot, it was the same way". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient stated that he had the 3 shots, he just had the Booster and confirms the shots were for covid, clarifying the Pfizer covid vaccine. He had the first shot in Mar2021, after that he had pain in the arm that was about a 4 out of 10 on a pain scale. This pain lasted about 4 days or 5 days; it would ease up then come back intermediately. With the second shot, it was the same way. He got a vaccine booster a month and a half ago, and he was in such pain. All the shots he received were in the upper shoulder. He lost weight. The Pain in his arm after this booster was a level 12 out of a pain scale of 1-10, he was in an arm sling for 5 days, says it hurt worse out of the sling. He had to go in to get a X-ray, to see if there were damages but there was no damage (it was negative). A technician told him, that the Pfizer company is not telling people about side effects in the joints of people. His pain was traveling down to the bicep and towards the elbow, and also down around the bottom of bicep its completely black and blue. He still do not have strength in the arm, that got the injection, but that it was on the lower bicep, not in the upper shoulder where he got the shot. It was aching pain. He was wondering if this is all normal side effects. When probed reporter type, caller states that he was basically been taught to be a nurse. His wife got Varicella and the nurse comes 3 days a week, his wife had had shots she would get and a wound on her buttocks, in which they clean it, and he would clean it. His wife fell and broke her back, and so he do not know how to operate the machine that had in which they hook you up, he had the portable one. She cannot eat that good, and she would get saline if she got dehydrated. They gave her Vitamin B or E shot whatever it was he does not know. She had vascular disease. Caller states that he got the vaccine at the community Hospital.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received wrong dose of Hep B, Pt receive pediatric dose.  Called manufacture advised CDC recommended another 0.5 dose of ped hep b to complete the dose if it was on the same day.  2nd dose administered.
Came to office on 6/10/01, with having "spots" on chest X 5 days. Spread to foot and back. No fever.
Swelling at injection site; headache; slight nausea; pain at injection site; This is a spontaneous report from a contactable consumer. A 43-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EH9899, first dose via an unspecified route of administration on 17Dec2020 13:00, in left arm at single dose for immunization. The patient's medical history was not reported. Concomitant medication included emtricitabine, tenofovir disoproxil fumarate (TRUVADA). The patient was vaccinated in the hospital. No other vaccine was receive in four weeks. The patient experienced swelling at injection site, headache, slight nausea and pain at injection site on 17Dec2020 18:00. No treatment was given to the patient for the events. The patient had no COVID prior to vaccination and no COVID test post vaccination. The events was reported as non serious. The patient has no known allergies. The outcome of the events was recovering.
Vaccine administered at 12:30 pm - approximately 4 hrs later, wife called stating patient had vomiting, diarrhea and high fever, weakness.
Low grade fever (1.5 degrees above normal), minor body aches, minor headache. All started about 11 hours after the dose and lasted until 30 hours after the dose.
LEG RASH; HEADACHE; This spontaneous report received from a patient concerned a 61 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A27A, and expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. Concomitant medications included isosorbide. On 02-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced leg rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, and leg rash. This report was non-serious.
Child started having a rash all over on Saturday 4-20-19, child was seen in office on 4-22-19 by Dr and was diagnosed with a reaction to the MMRV vaccine. Child had "classis measles rash". Child was well appearing in clinic other than rash.
Atypical CIDP, diagnosed 10/19/21. Patient just started on IVIg today (10/20/21). Symptoms include severe sensory gait ataxia and mild proximal upper and lower extremity weakness